Tricor
Company: Abbott Laboratories
Approval Status: Approved February 1998
Treatment for: high triglyceride levels
Areas: Cardiology/Vascular Diseases
Possible similar drugs: TriCor
General Information
Other Useful Resources
Tricor, a micronized form of the drug fenofibrate, has been approved for the treatment of very high triglyceride levels. Tricor is indicated as an adjunct to diet for the treatment of adults with very high serum triglyceride levels, specifically Types IV and V hyperlipidemia, who are not appropriately controlled by diet alone and are at risk of pancreatitis.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
